USP8: A Potential Drug Target and Biomarker for Ubiquitin Thiolesterase 8

Target Name: USP8

NCBI ID: G9101

USP8

USP8: A Potential Drug Target and Biomarker for Ubiquitin Thiolesterase 8

Introduction

Ubiquitin thiolesterase 8 (USP8) is a protein that plays a crucial role in the regulation of protein degradation in the body. Mutations in the USP8 gene have been linked to a range of disorders, including neurodegenerative diseases, autoimmune diseases, and developmental disorders. Despite the importance of USP8 in human health, little is known about its function or potential as a drug target or biomarker.

The USP8 gene and its function

USP8 is a member of the ubiquitin family of proteins, which are involved in the regulation of protein stability and degradation. Ubiquitin is a small protein that plays a central role in the degradation of many proteins, by covalently binding to their carbonyl terminus (29 amino acids residues) and subsequent hydrolyzing a thiol group at carbonyl side 20. This covalent binding of ubiquitin to proteins is a critical step in the regulation of protein stability and degradation, and is critical for the proper functioning of many cellular processes.

USP8 is involved in the regulation of protein degradation by ubiquitin thiolesterase, which is a protein that adds a thiol group to the carbonyl end of a ubiquitin protein. Ubiquitin thiolesterase 8 is a 23-kDa protein that is expressed in many different tissues and cells in the body. It is highly conserved, with only one known variant.

Mutations in the USP8 gene and its clinical impact

Mutations in the USP8 gene have been linked to a range of disorders, including neurodegenerative diseases, autoimmune diseases, and developmental disorders. One of the most well-known mutations is a missense mutation, which has been linked to the neurodegenerative disease known as ALS ( Amyotrophic Lateral Sclerosis).

The missense mutation in USP8 is missense, which means that it results in the substitution of an amino acid residue with another amino acid residue. This mutation has been shown to cause the aggregation of USP8 protein and contribute to the development of neurodegenerative symptoms.

Another mutation that has been linked to USP8 is a double mutation, which has been shown to cause the formation of aggregated USP8 protein and contribute to the development of autoimmune diseases.

The potential for USP8 as a drug target

The USP8 gene has great potential as a drug target due to its involvement in the regulation of protein stability and degradation. Recent studies have shown that USP8 can be targeted by small molecules, which can inhibit its activity as a ubiquitin thiolesterase.

One of the most promising small molecules is a compound called UB-801, which is a derivative of the amino acid leucine. UB-801 has been shown to inhibit the activity of USP8 as a ubiquitin thiolesterase, and to have potential as a drug for the treatment of neurodegenerative diseases.

Another small molecule that has been shown to inhibit USP8 is called UB-802, which is a derivative of the amino acid isoleucine. UB-802 has also been shown to inhibit the activity of USP8 as a ubiquitin thiolesterase and has potential as a drug for the treatment of autoimmune diseases.

The potential for USP8 as a biomarker

USP8 is also a potential biomarker for a range of disorders, including neurodegenerative diseases and autoimmune diseases. The development of USP8-based biomarkers could provide valuable information for the diagnosis and treatment of these disorders.

One of the most promising biomarkers for USP8 is a protein called USP8-associated protein 1 (USP8-AP1), which is a protein that is co-expressed with USP8 in many tissues and cells

Protein Name: Ubiquitin Specific Peptidase 8

Functions: Hydrolase that can remove conjugated ubiquitin from proteins and therefore plays an important regulatory role at the level of protein turnover by preventing degradation. Converts both 'Lys-48' an 'Lys-63'-linked ubiquitin chains. Catalytic activity is enhanced in the M phase. Involved in cell proliferation. Required to enter into S phase in response to serum stimulation. May regulate T-cell anergy mediated by RNF128 via the formation of a complex containing RNF128 and OTUB1. Probably regulates the stability of STAM2 and RASGRF1. Regulates endosomal ubiquitin dynamics, cargo sorting, membrane traffic at early endosomes, and maintenance of ESCRT-0 stability. The level of protein ubiquitination on endosomes is essential for maintaining the morphology of the organelle. Deubiquitinates EPS15 and controls tyrosine kinase stability. Removes conjugated ubiquitin from EGFR thus regulating EGFR degradation and downstream MAPK signaling. Involved in acrosome biogenesis through interaction with the spermatid ESCRT-0 complex and microtubules. Deubiquitinates BIRC6/bruce and KIF23/MKLP1. Deubiquitinates BACE1 which inhibits BACE1 lysosomal degradation and modulates BACE-mediated APP cleavage and amyloid-beta formation (PubMed:27302062)

The "USP8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets